Status:
COMPLETED
Promoting Positive Outcomes for Individuals With ASD: Linking Early Detection, Treatment, and Long-term Outcomes
Lead Sponsor:
Drexel University
Collaborating Sponsors:
University of California, Davis
University of Connecticut
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
16-58 years
Phase:
PHASE4
Brief Summary
Autism spectrum disorder (ASD) is defined by impaired social engagement and social communication, and repetitive, restricted, or stereotyped behaviors and interests. The average age of diagnosis in th...
Detailed Description
Autism spectrum disorder (ASD) is a serious neurodevelopmental disorder defined by impaired social engagement and social communication, in addition to the presence of repetitive, restricted, or stereo...
Eligibility Criteria
Inclusion
- child attended 18 m visiting at participating pediatric practice
- legal guardian is fluent in English or Spanish
Exclusion
- child has severe sensory or motor deficit that precludes completing standardized evaluation
Key Trial Info
Start Date :
November 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
2087 Patients enrolled
Trial Details
Trial ID
NCT03333629
Start Date
November 29 2017
End Date
June 30 2024
Last Update
August 16 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis
Sacramento, California, United States, 95817
2
University of Connecticut
Storrs, Connecticut, United States, 06269
3
Drexel University
Philadelphia, Pennsylvania, United States, 19104